Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome

NCT07558538 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

ARDS (Moderate or Severe)
ARDS (Acute Respiratory Distress Syndrome)

Interventions

DRUG: Recombinant Human Keratinocyte Growth Factor-2 for Inhalation (Lyophilized Powder)

Sponsor

Shanghai Zhongshan Hospital